Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway

por Wang, Tingting, Seah, Serena, Loh, Xinyi, Chan, Ching-Wan, Hartman, Mikael, Goh, Boon-Cher, Lee, Soo-Chin
Publicado 2015